[Charles Bonnet syndrome secondary to intravitreal ranibizumab in a patient with exudative age-related macular degeneration]

Med Clin (Barc). 2016 Jun 3;146(11):516-7. doi: 10.1016/j.medcli.2015.11.024. Epub 2015 Dec 31.

[Article in Spanish]

Authors

Pilar Cifuentes-Canorea¹, Nestor Ventura-Abreu², Julián García-Feijoo², Enrique Santos-Bueso²

Affiliations

¹ Unidad de Neurooftalmología, Servicio de Oftalmología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, España. Electronic address: pilarcifuca@gmail.com.
² Unidad de Neurooftalmología, Servicio de Oftalmología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, España.

PMID: 26749347
DOI: 10.1016/j.medcli.2015.11.024

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Angiogenesis Inhibitors / adverse effects*
Angiogenesis Inhibitors / therapeutic use
Female
Hallucinations / chemically induced*
Hallucinations / diagnosis
Humans
Intravitreal Injections
Ranibizumab / adverse effects*
Ranibizumab / therapeutic use
Syndrome
Wet Macular Degeneration / drug therapy*

Substances

Angiogenesis Inhibitors
Ranibizumab